News
Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body ...
Experts say supplement companies have tried to capitalize on the GLP-1 craze, putting the phrase in their product names, ...
Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...
Weight gain, low energy and stalled progress at the gym are issues many men face as they get older. But a new wave of ...
4d
The Print on MSNIndia sees 20k bariatric surgeries a year. But blockbusters Mounjaro, Wegovy are shaking up obesity arenaIndia's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 ...
Roughly one in three preteens and teens ages 12 to 17 in the United States had prediabetes in 2023, according to new data ...
FAT jabs do often sound like a magical quick fix to overeating and demanding hunger pangs. But the drugs can leave some ...
(1276.HK; 600276.SH) delivered a piece of good news for investors with positive trial data for a dual-acting obesity drug ...
While Ozempic is effective at treating type 2 diabetes and supporting weight loss, it can also come with side effects.
5d
ScienceAlert on MSNWeight Comes Back When You Stop Taking Drugs Like Ozempic, Study FindsWe've got fresh evidence for how weight can quickly be regained after weight-loss programs stop – but rather than looking at ...
Texas hairstylist Tim Bo Mack opened up to PEOPLE about his years-long struggle to lose weight. He finally found success ...
GLP-1 drugs have been compared to the discovery of penicillin, which changed the course of medicine by treating several ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results